Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Colorectal cancer screening

This article was originally published in The Gray Sheet

Executive Summary

Results of a study of more than 60,000 people screened for colorectal cancer, published on the Journal of the National Cancer Institute Web site April 6, show that African-Americans and Caucasians are equally likely to need a follow-up colonoscopy after a screening sigmoidoscopy, but that the former group is less likely to actually receive follow-up. In the U.S., colorectal cancer disproportionately affects black patients, who have a higher incidence and mortality rates. Of the 60,572 patients in the study, who are part of the larger Prostate, Lung, Colorectal and Ovarian Screening Trial, 23.6% of whites and 25.5% of blacks had abnormal results following flexible sigmoidoscopy. Of those subjects, 72.4% of whites and 62.6% of blacks received a follow-up colonoscopy. According to the study authors, the lower follow-up rates for blacks could be due to lower socioeconomic status. During a recent meeting at the National Institutes of Health, speakers cited high cost and lack of access to care among the barriers to colorectal cancer screening (1"The Gray Sheet" Feb. 8, 2010)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028720

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel